Michelson takes $1.2m for OCT system
This article was originally published in Clinica
Executive Summary
UK medical imaging start-up Michelson Diagnostics is set to complete development of its hand-held optical coherence technology (OCT) system for diagnosing and treating cancer, after having raised £600,000 ($1.2m) in additional funding. Some £250,000 came from Catapult Venture Managers, £50,000 from London See Capital and the rest from private investors. London-based Michelson said its OCT system allows for an "optical biopsy" by providing real-time images of sub-surface tissue without having to remove the tissue.